Summarized by Plex Health
Last Updated: 03 May 2022

Deutetrabenazine is used to treat involuntary muscle mass motions triggered by Huntington's disease. Deutetrabenazine is not a remedy for Huntington's disease and will not treat other symptoms of this condition. Deutetrabenazine is not a long-term remedy for involuntary movement disorders. Deutetrabenazine may be used for purposes not detailed in this medication guide. Do not use deutetrabenazine if you have taken reserpine in the previous 20 days, or if you have used an MAO inhibitor in the past 14 days. Do not use deutetrabenazine if you have taken reserpine in the previous 20 days, or if you have used an MAO inhibitor in the previous 14 days. People with Huntington's disease might have a higher risk of anxiety and suicidal thoughts or actions. Taking deutetrabenazine might cause symptoms similar to Parkinson's disease. Your family or other caretakers should be alert to changes in your state of mind or symptoms. If you are switching over from a comparable medication called tetrabenazine, take your first dosage of deutetrabenazine one day after your last dosage of tetrabenazine. Your doctor might periodically change your dose. Deutetrabenazine is usually taken 1 or 2 times each day with food and an entire glass of water. Tell your physician if you have trouble ingesting the tablet whole. Do not begin taking it again without your physician's advice if you stop taking deutetrabenazine for longer than 1 week. Take the medication as quickly as you can, however avoid the missed out on dosage if it is virtually time for your following dosage.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

PubChem - CovalentUnitCount

(Table source)
73437646C19H27NO3323.5CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC[2H]C([2H])([2H])OC1=C(C=C2[[email protected]]3CC(=O)[[email protected]@H](CN3CCC2=C1)CC(C)C)OC([2H])([2H])[2H]InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1/i3D3,4D3MKJIEFSOBYUXJB-VFJJUKLQSA-N(3R,11bR)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one2.9323.23675420323.2367542038.842500442362200001
*** If you want us to remove all links leading to your domain from and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.